LAUSR

The proinflammatory property of cisplatin is potentially destructive and contributes to the pathogenesis of acute kidney injury (AKI). The role and upstream regulatory mechanism of histone acetyltransferase 1 (HAT1) in acute kidney inflammation are still unknown. We performed RNA sequencing to filter differentially expressed microRNAs (miRNAs) in the kidney tissue of mice with AKI induced by cisplatin and ischemia‐reperfusion. Here, we found that miR‐486‐5p was upregulated and that the expression of HAT1 was reduced in AKI mouse models and injured human renal proximal tubular epithelial cell (HK‐2) model induced by cisplatin. miR‐486‐5p is implicated in cisplatin‐induced kidney damage in vivo. Bioinformatics analysis predicted a potential binding site between miR‐486‐5p and HAT1. The Luciferase reporter assay and Western blot confirmed that miR‐486‐5p directly targeted the 3′‐untranslated region of HAT1 mRNA and inhibited its expression in the cytoplasm of HK‐2 cells. In the in vitro study, inhibiting miR‐486‐5p reduced apoptosis, and the expression of proinflammatory mediators was induced by cisplatin in HK‐2 cells. Simultaneously, the downregulation of miR‐486‐5p inhibited the activation of the toll‐like receptor 4 (TLR4) and nuclear factor‐kappa B (NF‐κB). We further found that HAT1 could inhibit apoptosis and the activation of cisplatin on the TLR4/NF‐κB pathway and that the upregulation of miR‐486‐5p reversed this effect. Therefore, the upregulation of miR‐486‐5p targeting HAT1 promoted the cisplatin‐induced apoptosis and acute inflammation response of renal tubular epithelial cells by activating the TLR4/NF‐κB pathway, providing a new basis to highlight the potential intervention of regulating the miR‐486‐5p/HAT1 axis.